Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
2018 ◽
Vol 68
(3)
◽
pp. 517-527
◽
Alberto A. Chiappori
◽
Charles C. Williams
◽
Jhanelle E. Gray
◽
Tawee Tanvetyanon
◽
Eric B. Haura
◽
...
2010 ◽
Vol 78
(3)
◽
pp. S109-S110
G. Zhu
◽
A. Shi
◽
R. Yu
◽
Y. Li
◽
F. Li
◽
...
A. R. Jazieh
◽
R. Komrokji
◽
A. Gupta
◽
S. Patil
◽
D. Flora
◽
...
2021 ◽
Vol 16
(3)
◽
pp. S501
P. Deng
◽
H. Yang
◽
C. Chen
◽
C. Hu
◽
L. Cao
◽
...
2018 ◽
Vol 13
(10)
◽
pp. S320-S321
◽
S. Lin
◽
X. Lin
◽
D. Clay
◽
L. Yao
◽
I. Mok
◽
...
2021 ◽
Vol 16
(3)
◽
pp. S503
B. Han
◽
W. Zhang
◽
B. Zhang
◽
Y. Chen
◽
Y. Zhang
◽
...
2004 ◽
Vol 10
(15)
◽
pp. 5022-5026
◽
Martin J. Edelman
◽
Joseph I. Clark
◽
Kari Chansky
◽
Kathy Albain
◽
Nirmala Bhoopalam
◽
...
2016 ◽
Vol 77
(3)
◽
pp. 539-548
◽
Su Jin Heo
◽
Inkyung Jung
◽
Choong-kun Lee
◽
Jee Hung Kim
◽
Sun Min Lim
◽
...
1992 ◽
Vol 84
(3)
◽
pp. 150-154
◽
Close
Export Citation Format
Close
Share Document
Close